XML 71 R2.htm IDEA: XBRL DOCUMENT

Pay vs Performance Disclosure - USD ($)

12 Months Ended

Jan. 02, 2026

Dec. 27, 2024

Dec. 31, 2023

Dec. 30, 2022

Dec. 30, 2021

Pay vs Performance Disclosure

Pay vs Performance Disclosure, Table

In accordance with rules adopted by the SEC pursuant to Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the Company provides the following disclosure regarding executive compensation for its principal executive officer (“PEO”) and Non-PEO NEOs and the Company performance for each of fiscal years 2025, 2024, 2023, 2022 and 2021. The 2025 Compensation Committee did not solely rely on this pay versus performance disclosure in making its pay decisions for any of the fiscal years shown.


									Value of Initial Fixed Investments based on:(4)
Year (a)	Summary Compen- sation Table Total for PEO 1 ($)(1) (b)	Summary Compen- sation Table Total for PEO 2 ($)(1) (c)	Summary Compen- sation Table Total for PEO 3 ($)(1) (d)	Compen- sation Actually Paid to PEO 1 ($)(1)(2)(3) (e)	Compen- sation Actually Paid to PEO 2 ($)(1)(2)(3) (f)	Compen- sation Actually Paid to PEO 3 ($)(1)(2)(3) (g)	Average Summary Compen- sation Table for Non-PEO NEOs ($)(1) (h)	Average Compen- sation Actually Paid to Non-PEO NEOs ($)(1)(2)(3) (i)	TSR ($) (j)	Peer Group TSR ($) (k)	Net Income ($) (rounded to the nearest thousands) (l)	Revenue ($) (rounded to the nearest thousands)(5) (m)

2025	—	1,255,915	7,522,385	—	1,241,750	5,371,375	2,682,346	2,193,846	29.78	99.76	(80,448)	239,442
2024	—	7,821,216	—	—	2,747,432	—	2,562,044	1,214,377	30.55	95.30	(20,208)	313,901
2023	—	10,220,581	—	—	6,350,978	—	2,740,574	1,082,949	39.39	89.48	21,347	322,415
2022	6,501,953	—	—	1,027,645	—	—	2,053,028	1,162,152	61.26	89.02	39,665	284,391
2021	5,468,270	—	—	11,586,083	—	—	1,903,519	2,345,191	115.25	111.35	27,511	230,472

(1)

Stephen C. Farrell was the Company’s PEO for fiscal year 2025 (“PEO 3”), Thomas G. Frinzi was the Company’s PEO for fiscal years 2023 - 2025 (“PEO 2”) and Caren Mason was the Company’s PEO for fiscal years 2021 - 2022 (“PEO 1”). The individuals comprising the Non-PEO NEOs for each year presented are listed below:


2021	2022	2023	2024	2025

Patrick F. Williams	Patrick F. Williams	Patrick F. Williams	Patrick F. Williams	Patrick F. Williams
Scott Barnes	Scott Barnes	Scott Barnes	Warren Foust	Warren Foust
Keith Holliday	Keith Holliday	Keith Holliday	Magda Michna	Magda Michna
Hans Blickensdoerfer	James Francese	Warren Foust	Nathaniel Sisitsky	Nathaniel Sisitsky
				Deborah Andrews

(2)

The amounts shown for Compensation Actually Paid (“CAP”) have been calculated in accordance with Item 402(v) of Regulation S-K and do not reflect compensation actually earned, realized or received by the Company’s NEOs. These amounts reflect the Summary Compensation Table Total with certain adjustments as described in footnote (3) below.

(3)

CAP reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair value did not material differ from those disclosed at the time of grant. Amounts in the Exclusion of Stock Awards and Option Awards column are based on the amounts reported in the Stock Awards and Option Awards columns set forth in the Summary Compensation Table.


Year	Summary Compensation Table Total for PEO 2 ($)		Exclusion of Stock Awards and Option Awards for PEO 2 ($)		Inclusion of Equity Values for PEO 2 ($)			Compensation Actually Paid to PEO 2 ($)

2025		1,255,915		—		(14,165	)		1,241,750


Year	Summary Compensation Table Total for PEO 3 ($)		Exclusion of Stock Awards and Option Awards for PEO 3 ($)			Inclusion of Equity Values for PEO 3 ($)		Compensation Actually Paid to PEO 3 ($)

2025		7,522,385		(6,836,000	)		4,684,990		5,371,375


Year	Average Summary Compensation Table Total for Non-PEO NEOs ($)		Average Exclusion of Stock Awards and Option Awards for Non-PEO NEOs ($)			Average Inclusion of Equity Values for Non-PEO NEOs ($)		Average Compensation Actually Paid to Non-PEO NEOs ($)

2025		2,682,346		(1,600,021	)		1,111,521		2,193,846

The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:


Year	Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for PEO 2 ($)		Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for PEO 2 ($)			Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for PEO 2 ($)		Total - Inclusion of Equity Values for PEO 2 ($)

2025		—		(91,575	)		77,410		(14,165	)


Year	Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for PEO 3 ($)		Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for PEO 3 ($)		Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for PEO 3 ($)			Total - Inclusion of Equity Values for PEO 3 ($)

2025		4,720,000		—		(35,010	)		4,684,990


Year	Average Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Non-PEO NEOs ($)		Average Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Non-PEO NEOs ($)			Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Non-PEO NEOs ($)		Total - Average Inclusion of Equity Values for Non-PEO NEOs ($)

2025		1,111,173		(24,750	)		25,098		1,111,521

(4)

The Peer Group Total Shareholder Return (”TSR”) set forth in this table utilizes the S&P 400 Health Care Index, which the Company also utilizes in the stock performance graph required by Item 201(e) of Regulation S-K included in the Company’s Annual Report for the year ended January 2, 2026. The comparison assumes $100 was invested for the period starting January 1, 2021 through the end of the listed year in the Company and in the S&P 400 Health Care Index, respectively. Historical stock performance is not necessarily indicative of future stock performance.

(5)

The Company determined U.S. GAAP Revenue to be the most important financial performance measure used to link Company performance to CAP to its PEO and Non-PEOs in 2025. This performance measure may not have been the most important financial performance measure for fiscal years 2024, 2023, 2022 and 2021 and the Company may determine a different financial performance measure to be the most important financial performance measure in future years.

Company Selected Measure Name

Revenue

Named Executive Officers, Footnote

Thomas G. Frinzi was the Company’s PEO for fiscal years 2023 - 2025 (“PEO 2”) and Caren Mason was the Company’s PEO for fiscal years 2021 - 2022 (“PEO 1”). The individuals comprising the Non-PEO NEOs for each year presented are listed below:


2021	2022	2023	2024	2025

Patrick F. Williams	Patrick F. Williams	Patrick F. Williams	Patrick F. Williams	Patrick F. Williams
Scott Barnes	Scott Barnes	Scott Barnes	Warren Foust	Warren Foust
Keith Holliday	Keith Holliday	Keith Holliday	Magda Michna	Magda Michna
Hans Blickensdoerfer	James Francese	Warren Foust	Nathaniel Sisitsky	Nathaniel Sisitsky
				Deborah Andrews

Peer Group Issuers, Footnote

(4)

Adjustment To PEO Compensation, Footnote

reflects the exclusions and inclusions of certain amounts for the PEO and the Non-PEO NEOs as set forth below. Equity values are calculated in accordance with FASB ASC Topic 718, and the valuation assumptions used to calculate fair value did not material differ from those disclosed at the time of grant. Amounts in the Exclusion of Stock Awards and Option Awards column are based on the amounts reported in the Stock Awards and Option Awards columns set forth in the Summary Compensation Table.


Year	Summary Compensation Table Total for PEO 2 ($)		Exclusion of Stock Awards and Option Awards for PEO 2 ($)		Inclusion of Equity Values for PEO 2 ($)			Compensation Actually Paid to PEO 2 ($)

2025		1,255,915		—		(14,165	)		1,241,750


Year	Summary Compensation Table Total for PEO 3 ($)		Exclusion of Stock Awards and Option Awards for PEO 3 ($)			Inclusion of Equity Values for PEO 3 ($)		Compensation Actually Paid to PEO 3 ($)

2025		7,522,385		(6,836,000	)		4,684,990		5,371,375

The amounts in the Inclusion of Equity Values in the tables above are derived from the amounts set forth in the following tables:


Year	Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for PEO 2 ($)		Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for PEO 2 ($)			Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for PEO 2 ($)		Total - Inclusion of Equity Values for PEO 2 ($)

2025		—		(91,575	)		77,410		(14,165	)


Year	Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for PEO 3 ($)		Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for PEO 3 ($)		Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for PEO 3 ($)			Total - Inclusion of Equity Values for PEO 3 ($)

2025		4,720,000		—		(35,010	)		4,684,990

Non-PEO NEO Average Total Compensation Amount

$ 2,682,346

$ 2,562,044

$ 2,740,574

$ 2,053,028

$ 1,903,519

Non-PEO NEO Average Compensation Actually Paid Amount

$ 2,193,846

1,214,377

1,082,949

1,162,152

2,345,191

Adjustment to Non-PEO NEO Compensation Footnote


Year	Average Summary Compensation Table Total for Non-PEO NEOs ($)		Average Exclusion of Stock Awards and Option Awards for Non-PEO NEOs ($)			Average Inclusion of Equity Values for Non-PEO NEOs ($)		Average Compensation Actually Paid to Non-PEO NEOs ($)

2025		2,682,346		(1,600,021	)		1,111,521		2,193,846


Year	Average Year-End Fair Value of Equity Awards Granted During Year That Remained Unvested as of Last Day of Year for Non-PEO NEOs ($)		Average Change in Fair Value from Last Day of Prior Year to Last Day of Year of Unvested Equity Awards for Non-PEO NEOs ($)			Average Change in Fair Value from Last Day of Prior Year to Vesting Date of Unvested Equity Awards that Vested During Year for Non-PEO NEOs ($)		Total - Average Inclusion of Equity Values for Non-PEO NEOs ($)

2025		1,111,173		(24,750	)		25,098		1,111,521

Compensation Actually Paid vs. Total Shareholder Return

The following chart sets forth the relationship between Compensation Actually Paid to the Company’s PEO, the average of Compensation Actually Paid to the Company’s Non-PEO NEOs, and the cumulative TSR of the Company and S&P 400 Health Care Index over the five most recently completed fiscal years:

Compensation Actually Paid vs. Net Income

The following chart sets forth the relationship between Compensation Actually Paid to the Company’s PEO, the average of Compensation Actually Paid to the Company’s Non-PEO NEOs, and the Company’s net income over the five most recently completed fiscal years:

Compensation Actually Paid vs. Company Selected Measure

The following chart sets forth the relationship between Compensation Actually Paid to the Company’s PEO, the average of Compensation Actually Paid to the Company’s Non-PEO NEOs, and the Company’s revenue over the five most recently completed fiscal years:

Tabular List, Table

The following table presents the financial performance measures that the Company considers to have been the most important in linking Compensation Actually paid to the Company’s PEO and Non-PEO NEOs for 2025 to Company performance. The measures in this table are not ranked.

        U.S. GAAP Revenue

       

        Selling, General and Administrative

       

        Gross Margin

       

Total Shareholder Return Amount

$ 29.78

30.55

39.39

61.26

115.25

Peer Group Total Shareholder Return Amount

99.76

95.3

89.48

89.02

111.35

Net Income (Loss)

$ (80,448,000)

$ (20,208,000)

$ 21,347,000

$ 39,665,000

$ 27,511,000

Company Selected Measure Amount

239,442,000

313,901,000

322,415,000

284,391,000

230,472,000

Additional 402(v) Disclosure

Measure:: 1

Pay vs Performance Disclosure

Name

U.S. GAAP Revenue

Non-GAAP Measure Description

Measure:: 2

Pay vs Performance Disclosure

Name

Selling, General and Administrative

Measure:: 3

Pay vs Performance Disclosure

Name

Gross Margin

Caren Mason

Pay vs Performance Disclosure

PEO Total Compensation Amount

$ 6,501,953

$ 5,468,270

PEO Actually Paid Compensation Amount

$ 1,027,645

$ 11,586,083

PEO Name

Caren Mason

Thomas G. Frinzi

Pay vs Performance Disclosure

PEO Total Compensation Amount

$ 1,255,915

$ 7,821,216

$ 10,220,581

PEO Actually Paid Compensation Amount

$ 1,241,750

$ 2,747,432

$ 6,350,978

PEO Name

Thomas G. Frinzi

Stephen C. Farrell

Pay vs Performance Disclosure

PEO Total Compensation Amount

$ 7,522,385

PEO Actually Paid Compensation Amount

$ 5,371,375

PEO Name

Stephen C. Farrell

PEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

$ (14,165)

PEO | Thomas G. Frinzi | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

(91,575)

PEO | Thomas G. Frinzi | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

77,410

PEO | Stephen C. Farrell

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

4,684,990

PEO | Stephen C. Farrell | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

4,684,990

PEO | Stephen C. Farrell | Equity Awards Adjustments, Excluding Value Reported in Compensation Table

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

(6,836,000)

PEO | Stephen C. Farrell | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

4,720,000

PEO | Stephen C. Farrell | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

(35,010)

Non-PEO NEO

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

1,111,521

Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

1,111,521

Non-PEO NEO | Equity Awards Adjustments, Excluding Value Reported in Compensation Table

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

(1,600,021)

Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

1,111,173

Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

(24,750)

Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year

Pay vs Performance Disclosure

Adjustment to Compensation, Amount

$ 25,098